Scrip
Watson's income suffers despite revenue hike
05 November 2009
Simon Varcoe
Please Login to read the full article.
05 November 2009
Simon Varcoe
Watson Pharmaceuticals' net income slumped by 11% to $63 million in the third quarter after higher R&D and SG&A costs and income taxes more than offset a rise in the company's revenues.
The company's total revenues increased by 3% to $662.1 million, benefiting from both its generics and...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
